129 related articles for article (PubMed ID: 21845047)
1. Effect of size and processing method on the cytotoxicity of realgar nanoparticles in cancer cell lines.
Zhao W; Lu X; Yuan Y; Liu C; Yang B; Hong H; Wang G; Zeng F
Int J Nanomedicine; 2011; 6():1569-77. PubMed ID: 21845047
[TBL] [Abstract][Full Text] [Related]
2. Enhanced antitumor activity of realgar mediated by milling it to nanosize.
Tian Y; Wang X; Xi R; Pan W; Jiang S; Li Z; Zhao Y; Gao G; Liu D
Int J Nanomedicine; 2014; 9():745-57. PubMed ID: 24516332
[TBL] [Abstract][Full Text] [Related]
3. Realgar nanoparticle-based microcapsules: preparation and in-vitro/in-vivo characterizations.
Shi F; Feng N; Omari-Siaw E
J Pharm Pharmacol; 2015 Jan; 67(1):35-42. PubMed ID: 25196572
[TBL] [Abstract][Full Text] [Related]
4. Preparation and characterization of realgar nanoparticles and their inhibitory effect on rat glioma cells.
An YL; Nie F; Wang ZY; Zhang DS
Int J Nanomedicine; 2011; 6():3187-94. PubMed ID: 22238507
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the in vitro activity and in vivo bioavailability of realgar nanoparticles prepared by cryo-grinding.
Wu JZ; Ho PC
Eur J Pharm Sci; 2006 Sep; 29(1):35-44. PubMed ID: 16824739
[TBL] [Abstract][Full Text] [Related]
6. Caveolin-1 contributes to realgar nanoparticle therapy in human chronic myelogenous leukemia K562 cells.
Shi D; Liu Y; Xi R; Zou W; Wu L; Zhang Z; Liu Z; Qu C; Xu B; Wang X
Int J Nanomedicine; 2016; 11():5823-5835. PubMed ID: 27853367
[TBL] [Abstract][Full Text] [Related]
7. [Apoptosis effects of drug sensitivity leukemia cells induced by nano-realgar].
Wang YS; Zhou ST; Wei HL
Zhongguo Zhong Yao Za Zhi; 2013 Jul; 38(13):2202-5. PubMed ID: 24079254
[TBL] [Abstract][Full Text] [Related]
8. [Study on the effect of realgar nanoparticles anti-adenovirus in vitro].
Cheng M; Wang CX; Wang HF; Gou BD; Zhu Z; Wang MZ; Xu HR; Xu WB
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2011 Dec; 25(6):416-9. PubMed ID: 22734223
[TBL] [Abstract][Full Text] [Related]
9. Size effects of realgar particles on apoptosis in a human umbilical vein endothelial cell line: ECV-304.
Deng Y; Xu H; Huang K; Yang X; Xie C; Wu J
Pharmacol Res; 2001 Dec; 44(6):513-8. PubMed ID: 11735359
[TBL] [Abstract][Full Text] [Related]
10. Realgar (As4S4) nanoparticles and arsenic trioxide (As2O3) induced autophagy and apoptosis in human melanoma cells in vitro.
Pastorek M; Gronesova P; Cholujova D; Hunakova L; Bujnakova Z; Balaz P; Duraj J; Lee TC; Sedlak J
Neoplasma; 2014; 61(6):700-9. PubMed ID: 25150315
[TBL] [Abstract][Full Text] [Related]
11. Anti-tumor effects and apoptosis induction by Realgar bioleaching solution in Sarcoma-180 cells in vitro and transplanted tumors in mice in vivo.
Xie QJ; Cao XL; Bai L; Wu ZR; Ma YP; Li HY
Asian Pac J Cancer Prev; 2014; 15(6):2883-8. PubMed ID: 24761919
[TBL] [Abstract][Full Text] [Related]
12. Realgar, a traditional Chinese medicine, induces apoptosis of HPV16-positive cervical cells through a HPV16 E7-related pathway.
Ding W; Ji T; Xiong W; Li T; Pu D; Liu R
Drug Des Devel Ther; 2018; 12():3459-3469. PubMed ID: 30410307
[TBL] [Abstract][Full Text] [Related]
13. [Effect of nano-realgar on proliferation and apoptosis of human cervical carcinoma cells].
Li L; Wang L; Xiao S; Li Y; Cheng C; Xue M
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2015 Oct; 40(10):1068-75. PubMed ID: 26541839
[TBL] [Abstract][Full Text] [Related]
14. [Study on the effect of realgar nanoparticles on reducing the respiratory syncytial virus type A (RSV-a) replication in vitro].
Cheng M; Zhao HL; Wang CX; Wang HF; Zhang Y; Gou BD; Zhu Z; Wang MZ; Xu WB
Bing Du Xue Bao; 2012 Jan; 28(1):45-50. PubMed ID: 22416349
[TBL] [Abstract][Full Text] [Related]
15. Arsenic sulfide, the main component of realgar, a traditional Chinese medicine, induces apoptosis of gastric cancer cells in vitro and in vivo.
Zhang L; Tian W; Kim S; Ding W; Tong Y; Chen S
Drug Des Devel Ther; 2015; 9():79-92. PubMed ID: 25565771
[TBL] [Abstract][Full Text] [Related]
16. [Effect of realgar on induction of apoptosis in DLBCL cell line SU-DHL-4 and its possible mechanisms].
Shi LL; Zhu HC; Zhang M; Liu YF; Wang Y; Zhao J; Lei F; He PC
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Jun; 22(3):729-34. PubMed ID: 24989285
[TBL] [Abstract][Full Text] [Related]
17. Nano-realgar suppresses lung cancer stem cell growth by repressing metabolic reprogramming.
Yang FR; Zhao YF; Hu XW; Liu ZK; Yu XD; Li CY; Li XR; Li HJ
Gene; 2021 Jul; 788():145666. PubMed ID: 33887368
[TBL] [Abstract][Full Text] [Related]
18. Membrane-associated cytotoxicity induced by realgar in promyelocytic leukemia HL-60 cells.
Ye HQ; Gan L; Yang XL; Xu HB
J Ethnopharmacol; 2006 Feb; 103(3):366-71. PubMed ID: 16174554
[TBL] [Abstract][Full Text] [Related]
19. Realgar-induced apoptosis of cervical cancer cell line Siha via cytochrome c release and caspase-3 and caspase-9 activation.
Cheng YX; Liu R; Wang Q; Li BS; Xu XX; Hu M; Chen L; Fu Q; Pu DM; Hong L
Chin J Integr Med; 2012 May; 18(5):359-65. PubMed ID: 21526368
[TBL] [Abstract][Full Text] [Related]
20. Properties of realgar bioleaching using an extremely acidophilic bacterium and its antitumor mechanism as an anticancer agent.
Chen P; Xu R; Yan L; Wu Z; Wei Y; Zhao W; Wang X; Xie Q; Li H
Biol Res; 2017 May; 50(1):17. PubMed ID: 28532516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
